Latest Articles

Publication Date
Endometriosis Treatment Market Size, Share | Forecast [2032] - Fortune Business Insights

Endometriosis Treatment Market Size, Share | Forecast [2032] Fortune Business Insights

Published: Nov. 7, 2025, 11:32 a.m.
Endometrial cancer: Building the best care team, from diagnosis to treatment - mcpress.mayoclinic.org

Endometrial cancer: Building the best care team, from diagnosis to treatment mcpress.mayoclinic.org

Published: Nov. 6, 2025, 9:50 p.m.
HMI-115, a Potential First-in-Class Treatment for Endometriosis, Published Proof-of-Concept Phase II Clinical Trial Results in The Lancet Obstetrics, Gynaecology, & Women's Health - The Malaysian Reserve

HMI-115, a Potential First-in-Class Treatment for Endometriosis, Published Proof-of-Concept Phase II Clinical Trial Results in The Lancet Obstetrics, Gynaecology, & Women's Health The Malaysian Reserve

Published: Nov. 6, 2025, 8:25 p.m.
Would you travel abroad for endometriosis treatment? - Newstalk

Would you travel abroad for endometriosis treatment? Newstalk

Published: Nov. 6, 2025, 1:39 p.m.
Association Between Previous Surgical Treatment and Outcomes of Repeat Endometriosis Surgery - medtalks.in

Association Between Previous Surgical Treatment and Outcomes of Repeat Endometriosis Surgery medtalks.in

Published: Nov. 6, 2025, 11:13 a.m.
HMI-115, a Potential First-in-Class Treatment for Endometriosis, Published Proof-of-Concept Phase II Clinical Trial Results in The Lancet Obstetrics, Gynaecology, & Women's Health - Fidelity

HMI-115, a Potential First-in-Class Treatment for Endometriosis, Published Proof-of-Concept Phase II Clinical Trial Results in The Lancet Obstetrics, Gynaecology, & Women's Health Fidelity

Published: Nov. 6, 2025, 4:32 a.m.
HMI-115, a Potential First-in-Class Treatment for Endometriosis, Published Proof-of-Concept Phase II Clinical Trial Results in The Lancet Obstetrics, Gynaecology, & Women's Health - PR Newswire

HMI-115, a Potential First-in-Class Treatment for Endometriosis, Published Proof-of-Concept Phase II Clinical Trial Results in The Lancet Obstetrics, Gynaecology, & Women's Health PR Newswire

Published: Nov. 6, 2025, 4:08 a.m.
Sonographic and Clinical Progression of Adenomyosis and Coexisting Endometriosis: Long-Term Insights and Management Perspectives.

Objectives: To evaluate the impact of hormonal therapy on the evolution of painful symptoms in premenopausal women with adenomyosis, with or without concomitant endometriosis, over an 18-month follow-up period. This …

Published: Nov. 6, 2025, midnight
Endometriosis Treatment Market to Reach USD 4.95 Billion by 2032, Growing at 12.30% CAGR - newstrail.com

Endometriosis Treatment Market to Reach USD 4.95 Billion by 2032, Growing at 12.30% CAGR newstrail.com

Published: Nov. 5, 2025, 1:38 p.m.
In vitro fertilization-assisted pregnancy combined with high-intensity focused ultrasound treatment in patients with endometriosis and adenomyosis with successful pregnancy: a case report - Journal of Medical Case Reports

In vitro fertilization-assisted pregnancy combined with high-intensity focused ultrasound treatment in patients with endometriosis and adenomyosis with successful pregnancy: a case report Journal of Medical Case Reports

Published: Nov. 5, 2025, 12:28 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!